Authors
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program ImplementationThis article discusses “lessons learned” on managing psychosocial distress and the optimal strategies to promote institutions’ adoption of distress screening.
Latest:
When to Order an MRI in the Initial Evaluation and Management of Prostate CancerThis article summarizes the current role of multiparametric MRI in the diagnosis, risk assessment, and treatment of prostate cancer.
Latest:
When to Order an MRI in the Initial Evaluation and Management of Prostate CancerThis article summarizes the current role of multiparametric MRI in the diagnosis, risk assessment, and treatment of prostate cancer.
Latest:
Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast CancerAn otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?
Latest:
Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast CancerAn otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?
Latest:
Herb-Drug Interactions in Cancer CareIn this article, we describe the mechanisms via which interactions between herbs and prescription drugs may occur, and highlight four popular herbs and a medicinal mushroom commonly used by cancer patients, along with reports of their interactions with standard drugs.
Latest:
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited TissueDue to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
Latest:
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited TissueDue to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
Latest:
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited TissueDue to the high rate of EGFR T790M mutations seen in NSCLC patients, the thoracic tumor board recommends genomic testing for this alteration; read our case of a 69-year-old woman with metastatic disease.
Latest:
Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are GoingThis article discusses the advances in HER2-targeted therapy, in both the metastatic and adjuvant settings, with a focus on those with early-stage breast cancer.
Latest:
Integrating Immunotherapy Into Colorectal Cancer CareUntil recent studies were reported, immunotherapy was thought to be ineffective for colorectal cancer; this article provides guidance on how to incorporate immunotherapy into this setting.
Latest:
Recognizing the Side Effects of Newly Approved CLL TherapiesDr. Ian Flinn spoke with Cancer Network about incorporating the newest approved therapies for the management of CLL.
Latest:
Using Exosomes to Help Cancer DiagnosisDr. Raghu Kalluri speaks with Cancer Network about the role of exosomes in cancer progression ahead of his presentation at ESMO 2018.
Latest:
FDA Approves Two New Indications and Dosage Form for PembrolizumabIn this installment of Oncology Drug Updates, updates to FDA approvals for pembrolizumab in the treatment of lung cancer and RCC are highlighted.
Latest:
Managing Anxiety and Depression in Cancer PatientsDr. William Pirl speaks with Cancer Network about cancer patients' moods influencing their well-being and survival.
Latest:
2019 World Conference Of Lung Cancer Round-UpFive notable abstracts from the 2019 World Conference on Lung Cancer (WCLC).
Latest:
Bone-Targeted Therapy in Early Breast CancerIn this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Latest:
Bone-Targeted Therapy in Early Breast CancerIn this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Latest:
Bone-Targeted Therapy in Early Breast CancerIn this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Latest:
Bone-Targeted Therapy in Early Breast CancerIn this article, we describe the role of bone-targeted therapies, specifically for managing early breast cancer, by reviewing their bone-specific and cancer-specific benefits.
Latest:
Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research RecommendationsThis review article written by Danielle Gentile, PhD, et al, reviews the management of cancer-related fatigue in integrative oncology.
Latest:
Pros and Cons of Dietary Strategies Popular Among Cancer PatientsThis article discusses some of the popular diets that cancer patients pursue, and the positive and negative aspects associated with these diets.
Latest:
Considerations in the Care of Non–Small-Cell Lung Cancer: The Value ImperativeThis article discusses ways in which the oncologist can incorporate value into the management of patients with lung cancer and comply with the underlying principles of the Choose Wisely Campaign, as well as recent ASCO and ESMO initiatives, to bend the cost curve downwards while maintaining efficacy.
Latest:
Considerations in the Care of Non–Small-Cell Lung Cancer: The Value ImperativeThis article discusses ways in which the oncologist can incorporate value into the management of patients with lung cancer and comply with the underlying principles of the Choose Wisely Campaign, as well as recent ASCO and ESMO initiatives, to bend the cost curve downwards while maintaining efficacy.
Latest:
Role of Temozolomide in the Treatment of Cancers Involving the Central Nervous SystemIn this article, we review the role of temozolomide in the management of patients with primary brain tumors, brain metastases, leptomeningeal carcinomatosis, and other selected CNS cancers.
Latest:
TNFR2's Role in Influencing Tumor TissueDr. Denise Faustman spoke with Cancer Network about TNFR2 and its emerging role in understanding regulatory T-cell behavior.
Latest:
Epigenetics, BRCA, and Inherited Cancers: Dr. Newman Connects the DotsDr. William Newman spoke with Cancer Network about the roles of epigenetic silencing in heritable cancer syndromes.
Latest:
ctDNA Positivity Appears to Predict Risk of Recurrence, Benefit from Adjuvant Chemotherapy in Resectable CRCAn expert from Natera discusses ctDNA’s predictive and prognostic value in resectable colorectal cancer based on data from the GALAXY cohort of the CIRCULATE-JAPAN platform study.
